Board of Directors strengthened to support the Company’s strategic development Croissy-Beaubourg and Montpellier, March 1, 2017, 5:45pm (CET) – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specialized in in vitro diagnostics and theranostics, has today…
Croissy-Beaubourg and Montpellier, January 26, 2017 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, announces that it has been selected by the Eurostars-2 program to receive financial support for…
Croissy-Beaubourg and Montpellier, January 24, 2017 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announces today its financial reporting schedule for 2017.Financial publications will be released after market close.…